Dr. Mohammed F. Islam, MD
Hematology & Oncology (Hematology & Oncology Physician)
- Medicare participating
At a glance
- Years since graduation
- 43
- In the NPI registry since
- 2005
- Medicare patients seen, 2024
- 429
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Hematology & Oncology Physician primary
PA license MD065794L
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- UPMC Presbyterian Shadyside Pittsburgh, PA
- Allegheny General Hospital Pittsburgh, PA
- Jefferson Hospital Jefferson Hills, PA
- West Penn Hospital Pittsburgh, PA
- Grove City Medical Center Grove City, PA
Medical groups
- Dlp Conemaugh Physician Practices LLC (293 clinicians)
- Allegheny Clinic Medical Oncology (97 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 429
- Services billed
- 1,083
- Patients’ average age
- 73
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 403 | 248 |
| Established patient office or other outpatient visit, 40-54 minutes | 354 | 85 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 157 | 108 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 144 | 68 |
| Established patient office or other outpatient visit, 20-29 minutes | 84 | 74 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 61 | 43 |
| New patient office or other outpatient visit, 30-44 minutes | 41 | 41 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 40 | 40 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 38 | 32 |
| Administration of chemotherapy into vein, 1 hour or less | 34 | 13 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 5 companies reported 5 payments worth $163 in total to this clinician.
| AstraZeneca Pharmaceuticals LP | $68.49 |
|---|---|
| Regeneron Healthcare Solutions, Inc. | $34.61 |
| Sumitomo Pharma America, Inc. | $24.82 |
| E.r. Squibb & Sons, L.l.c. | $20.68 |
| Incyte Corporation | $14.51 |
| Education | $93.31 |
|---|---|
| Food and Beverage | $69.80 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP Jul 30, 2025 | Education IMFINZI · Oncology · in-kind Company’s descriptionJournal Article | $68.49 |
| Sumitomo Pharma America, Inc. Aug 14, 2025 | Education ORGOVYX · PROSTATE CANCER · in-kind | $24.82 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.